Transcription factor Sp1 has recently been shown to be overexpressed in a number of human cancers and its overexpression contributes to malignant transformation. Sp1 regulates the expression of a number of genes participating in multiple aspects of tumorigenesis such as angiogenesis, cell growth and apoptosis resistance. To better understand the role of increased Sp1 levels on apoptosis regulation we have used retroviruses to overexpress this protein in haematopoietic Baf-3 cells and in 3T3 fibroblasts. We have also used inducible expression systems to control ectopic Sp1 levels in different cell types. Surprisingly, Sp1 overexpression on its own induces apoptosis in all the cellular models tested. The apoptotic pathways induced by Sp1 overexpression are cell type specific. Finally, using a truncated form of Sp1, we show that Sp1-induced apoptosis requires its DNA-binding domain. Our results highlight that Sp1 levels in untransformed cells must be tightly regulated as Sp1 overexpression leads to the induction of apoptosis. Our results also suggest that cancer cells overexpressing Sp1 can avoid Sp1-induced apoptosis.
Introduction
Transcription factor Sp1 is a zinc-finger protein and was the first member identified of the growing Sp/XKLF family that binds GC-rich elements (Philipsen and Suske, 1999) . GC-rich sequences are common regulatory elements in promoters of housekeeping genes as well as many tissue-specific genes. Sp1 has traditionally been considered as a constitutive transcription factor regulating basal promoters activity because it is expressed in all cell types and Sp1-binding sites are found in the promoters of many housekeeping genes. However, it is becoming increasingly clear that Sp1 is also involved in tissue-specific gene expression, its activity being finely modulated by a variety of stimuli through multiple posttranslational modifications (Bouwman and Philipsen, 2002) .
Tumorigenesis is a multistep process involving cell proliferation, apoptosis resistance and angiogenesis. In that respect, it is interesting to note that Sp1 participates in the regulation of genes involved in all these aspects of tumorigenesis (Black et al., 2001) . Moreover, numerous studies have documented that Sp1 activity and/or Sp1 expression levels are elevated in various human cancers. Elevated levels of Sp1 protein have been observed in human primary gastric tumours, in pancreatic adenocarcinomas and in thyroid tumours but not in normal tissues (Shi et al., 2001; Chiefari et al., 2002; Wang et al., 2003) . In gastric cancer, elevated Sp1 expression levels have been correlated with a poor survival (Yao et al., 2004) . Sp1-binding activity was shown to be higher in human breast carcinomas and in hepatocellular carcinomas than in corresponding normal tissues (Lietard et al., 1997; Zannetti et al., 2000) . In mice, both Sp1 mRNA level and Sp1-binding activity were shown to be increased during skin tumour progression (Kumar and Butler, 1999) . Recently, a link between alterations of Sp1 expression/activity and transformation has been demonstrated. Indeed, inhibition of Sp1 overexpression in human fibrosarcoma cell lines leads to reduced tumours formation in athymic mice and to a decreased ability to form colonies in agarose (Lou et al., 2005) . These findings confirm previous data where transfection of lung cancer and glioma cell lines with dominantnegative Sp1 decoy oligonucleotides inhibited their proliferation and their invasiveness in vitro (Ishibashi et al., 2000) . All together, these findings show that Sp1 is overexpressed or overactivated in a number of cancers and that its activity plays a role in late stage of carcinogenesis.
Cancer progression requires resistance to apoptosis and accumulating evidence suggests that Sp1 is involved in the regulation of apoptosis. The promoters of many antiapoptotic genes (bcl-2, bcl-x, survivin) as well as many proapoptotic genes (bax, trail, fas, fas-ligand, caspase-8 and caspase-3) contain Sp1-binding sites (Black et al., 2001) . Although embryonic stem cells with inactivated Sp1 are viable, and grow and differentiate normally, Sp1 deficient embryos are retarded in development and die after day 10 of gestation (Marin et al., 1997) . Sp1 deficiency causes a cell autonomous defect as when injected into wild-type blastocysts, Sp1-deficient embryonic stem cells contribute to every tissue of chimeras but only until day 10. These results suggest that Sp1 is required for cell survival and/or proliferation (Marin et al., 1997) . Accordingly, sustained expression of Sp1 protects primary cortical neurons from cell death induced by oxidative stress or DNA damage (Ryu et al., 2003b) . In the same cells, acetylation of Sp1 has recently been associated with increased Sp1-dependent transcription and resistance of neurons to oxidative stressinduced death in vitro and in vivo (Ryu et al., 2003a) . However, Sp1 has also been associated with apoptosis induction. Hence, Sp1 phosphorylation regulates smooth muscle cells apoptosis via extracellular FasLigand-Fas engagement (Kavurma et al., 2001) . In the same cells, Sp1 transfection induces cell death by a mechanism that involves the repression of the cell cycle inhibitor p21 expression (Kavurma and Khachigian, 2003) . Finally, inhibitors of histone deacetylases selectively induce the apoptosis of tumour cells via the induction of tumour-necrosis factor-related apoptosisinducing ligand (TRAIL) expression (Nebbioso et al., 2005) . This process is dependent on the acetylation and the recruitment of Sp1 and Sp3 to the trail promoter. Collectively, these results suggest an important role for Sp1 in the regulation of apoptosis that needs, however, to be better defined.
To establish the effect of Sp1 on the regulation of apoptosis we have overexpressed this protein in various cell lines. Our work demonstrates that Sp1 overexpression leads to the activation of a program of apoptosis in immortalized nontransformed mouse and hamster fibroblasts and in mouse pro-B cell line. The apoptotic pathways induced by Sp1 overexpression are cell type specific and require its DNA-binding domain. Finally, by monitoring the expression of apoptosis regulatory genes we show that the apoptotic pathway induced by Sp1 in Baf-3 cells is different from the ones previously described.
Results

Sp1 overexpression is detrimental
To test the effect of Sp1 on apoptosis regulation we have ectopically expressed human Sp1 in interleukin-3 (IL-3)-dependent haematopoietic Baf-3 cells. We have used a bicistronic retrovirus coding for full-length flagged Sp1 and the cell surface marker CD2 to identify transduced cells. Within 1 day of culture with retroviruses, a substantial proportion of Baf-3 cells were infected as revealed by CD2 expression (Figure 1a) . Transduction of cells with full-length flagged Sp1 encoding retrovirus resulted in Sp1 protein overexpression as visualized in Sp1-infected cells purified by magnetic selection with anti-CD2 antibody (Figure 1b) . Surprisingly, 2 days after infection with retrovirus coding for full-length flagged Sp1, the proportion of CD2-positive cells started to decrease (Figure 1a ) and 1 day later almost all CD2-positive cells were lost. In contrast, the percentage of CD2-expressing cells in the population infected by the control retrovirus was maintained over time and cells could be grown for long period of time ( Figure 1a and data not shown). These results suggest that elevation of Sp1 levels in Baf-3 cells is detrimental for their growth in culture.
The full-length flagged Sp1 we have used codes for the complete amino sequence of Sp1 (785 amino acids long) (Takahara et al., 2000) . As most studies on Sp1 to date have been performed using a truncated form lacking the seven NH2-terminal residues (Sp1 778) (Suske, 1999) , we have also studied the effect of Sp1 778. Twenty-four hours post-transduction a similar proportion of Baf-3 cells were transduced by retroviruses coding for the different Sp1 constructs (Figure 1a ). However, 2 days later almost all Sp1-infected cells were lost indicating that the detrimental effect of Sp1 is not isoform specific. 
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The results were extended to another cell type, the murine 3T3 fibroblast cell line. Although at early time point a high proportion of 3T3 expressed CD2 following transduction with control or Sp1 encoding retroviruses, the percentage of cells expressing CD2 was drastically reduced 7 days after transduction with Sp1 ( Figure 1c) . Therefore, the loss of Sp1 overexpressing cells is a general phenomenon.
Sp1 overexpression induces apoptosis
The detrimental effect of Sp1 on cell maintenance in culture could be due to at least two mechanisms, that is, cell cycle arrest or cell death. To investigate the latter possibility, we have analysed several markers of apoptosis on Sp1-infected Baf-3 cells. Two days after infection, Sp1-transduced Baf-3 cells displayed a profound increase in annexin V staining, reflecting the phosphatidylserine externalization at the plasma membrane, an event occurring at an early stage of apoptosis ( Figure 2a ). Notably, time course studies of phosphatidylserine externalization mirrored the loss of CD2-expressing cells. Moreover, caspase-3 was activated in Sp1-transduced Baf-3 cells but not in control-infected cells as revealed by intracellular staining (Figure 2b) . Consistently, incubation of Sp1-transduced cells with pan-caspase inhibitor Z-VAD-FMK inhibited Sp1-induced phosphatidylserine externalization in a dosedependent manner (Figure 2c ). Maximal inhibition of Sp1-induced apoptosis occurred at 500 mM of Z-VAD-FMK. This is similar to the dose required to inhibit apoptosis induced by IL-3 starvation in Baf-3 cells (Leverrier et al., 1999) . Altogether, these results indicate that Sp1 overexpression induces a caspase-dependent apoptosis.
Overexpression of antiapoptotic genes from the Bcl-2 family (such as bcl-x or nr-13) delays apoptosis commitment induced by a large number of apoptotic stimuli (Mangeney et al., 1996) . Therefore, we have tested the effect of antiapoptotic genes bcl-X and nr-13 expression on Sp1-induced apoptosis in Baf-3 cells. Two days after infection, Sp1-transduced Baf-3 cells overexpressing bcl-X or nr-13 genes (Mangeney et al., 1996; Thomas et al., 1998) displayed reduced phosphatidylserine externalization compared to Sp1-transduced parental Baf-3 cells (Figure 2d ). Therefore, Sp1 activates an apoptotic pathway in Baf-3 cells that is sensitive to inhibition by Bcl-2 family members.
The results were extended to another cell line, a subclone of the CCL39 hamster fibroblast cell line (CCL39 WT2 clone) in which overexpression of fulllength human Sp1 is induced with tetracycline (Milanini-Mongiat et al., 2002) . We took advantage of the CCL39 WT2 cells in which induction of different levels of Sp1 were obtained by addition of tetracycline in a dose-dependent fashion ( Figure 3a ). Ectopic Sp1 expression was detectable by incubating the cells for 48 h with 0.01 mg/ml tetracycline and was maximal with 1 mg/ml tetracycline. Figure 3b shows that addition of high doses of tetracycline (0.1-1 mg/ml) to CCL39 WT2 cells resulted in apoptosis as detected by phosphatidylserine externalization, whereas addition of low dose of tetracycline (0.01 mg/ml) did not. These results confirm that deregulated expression of high doses of Sp1 leads to apoptotic cell death.
Apoptotic pathways activated by Sp1 overexpression are cell type specific A recent work has revealed that a subtype of smooth muscle cells expressing abundant levels of Sp1 undergoes greater spontaneous apoptosis that is correlated with the production of the death agonist Fas-ligand 
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E Deniaud et al (Kavurma et al., 2001) . This prompted us to investigate whether the Fas pathway was involved in Sp1-induced apoptosis in Baf-3 cells. Baf-3 cells express Fas/CD95 constitutively albeit at very low level and can be killed through Fas by a caspase-8-dependent mechanism (Munoz-Pinedo et al., 2001) . Pan-caspase inhibitor Z-VAD-FMK and caspase-8 inhibitor Z-IETD-FMK both inhibited Fas-induced apoptosis of control-infected Baf-3 cells (Figure 4a ). In contrast, Z-VAD-FMK but not Z-IETD-FMK inhibited Sp1-induced apoptosis in Baf-3 cells. These results show that in Baf-3 cells whereas Fas-induced apoptosis is caspase-8 dependent, Sp1-induced apoptosis is caspase-8 independent.
In contrast to Baf-3 cells, both pan-caspase inhibitor Z-VAD-FMK and caspase-8 inhibitor Z-IETD-FMK inhibited Sp1-induced apoptosis of CCL39 WT2 fibroblasts (Figure 4b ). Altogether these results indicate that Sp1-induced apoptotic pathways are caspase-8 dependent in CCL39 WT2 cells but caspase-8 independent in Baf-3 cells suggesting a cell type-specific death-induced pathway.
Induction of apoptosis by Sp1 requires its DNA-binding domain Recent studies have highlighted that some transcription factors such as p53 or papillomavirus E2 can induce apoptosis independently of their transcriptional activities (Demeret et al., 2003; Chipuk et al., 2004) . In the case of p53, cytosolic localization of endogenous wild-type protein is sufficient for apoptosis induction. We then asked whether this could be the case for Sp1. We have constructed a truncated form of Sp1 (Sp1DZn) lacking its DNA-binding domain that consists in 3 zincfingers (Philipsen and Suske, 1999) . Baf-3 cells were transduced with either full-length Sp1 or Sp1DZn and examined thirty hours later. Transduced full-length Sp1 was transcriptionally active as purified Sp1-infected cells showed increased mRNA levels coding for lactate deshydrogenase (LDH) A (Figure 5a ), a gene which basal expression level is regulated by Sp1 (Short et al., 1994) . As expected, transduced Sp1DZn did not induce LDH-A transcription although the protein expression Apoptosis induction by Sp1 E Deniaud et al levels of Sp1DZn were higher than Sp1 expression levels (Figure 5b ). When the cells were examined by confocal fluorescent microscopy full-length Sp1 was detected in the nucleus of transduced cells (Figure 5c ), whereas Sp1DZn accumulated preferentially in the cytoplasm. This confirms a previous report indicating that the nuclear localization sequences of Sp1 are included in its DNA-binding domain (Lomberk and Urrutia, 2005) . We then analysed the viability of transduced cells and observed that Sp1 induced apoptosis, whereas Sp1DZn did not (Figure 5d ). This was not due to delayed apoptosis associated with Sp1DZn as Sp1DZn-transduced cells could be grown for long period of time (data not shown). Altogether, these results indicate that Sp1 proapoptotic activity is linked to its nuclear localization and/or to its DNA-binding activity. The latter would indicate that Sp1 induces Baf-3 cells apoptosis through a transcription-dependent mechanism.
Gene expression in Sp1 overexpressing Baf-3 cells To further investigate the mechanisms of apoptosis induction by Sp1, we introduced an inducible tetracycline (tet)-off expression system in Baf-3 cells (see Materials and methods). In the absence of doxycyline, expression of the ectopic full-length Sp1 was rapidly induced as detected at the mRNA and protein levels (Figure 6a and b) . At 30 h after doxycycline removal, Baf-3-Sp1 cells entered apoptosis as revealed by loss of plasma membrane integrity, phosphatidylserine externalization and loss of mitochondrial membrane potential (Figure 6a and data not shown), confirming that Sp1 
E Deniaud et al overexpression induces apoptosis. We subsequently analysed the expression of a panel of genes involved in the regulation of apoptosis (Bcl-2 family), in the induction of apoptosis (death receptors family) or in the effector phase of apoptosis (caspases family) (Figure 6c ). Gene expression was monitored at different time points (17, 24 and 30 h following doxycyline removal) when cells already expressed high levels of Sp1 protein but before the onset of apoptosis. Cells grown in the presence of doxycycline were used as controls. Upon Sp1 induction, among the transcripts analysed, the one that showed the strongest variation are the one coding for the antiapoptotic protein Bcl-X L (2.1-fold decrease708 30 hours after doxycyline removal, n ¼ 3 independent experiments) and for the proapoptotic protein Bax (1.7-fold decrease 70.5). The other transcripts from the Bcl-2 family, the caspases family and the death receptors that were expressed in Baf-3 cells did not show any significant variation in their expression levels following Sp1 induction. Some genes previously linked with Sp1-induced apoptosis such as Fas-Ligand or TRAIL were not detected in Baf-3 cells and were not induced by Sp1 upregulation.
Discussion
Many transcription factors have been implicated in the induction or the inhibition of apoptosis. Some transcription factors such as ATFx seem to have purely antiapoptotic activities (Persengiev et al., 2002) . E2F-1 has both activities as it is required for T-cell apoptosis in vivo and its overexpression induces apoptosis in a number of cell lines but inhibits apoptosis in others such as Baf-3 cells (Field et al., 1996; Gala et al., 2001 ). However, increased activity of many transcription factors such as c-Jun, c-Fos, E2F-1, p75 c-Myb, FKH-L1, c-Myc and p53 induces apoptosis or sensitises the cells to proapoptotic stimuli (Harrington et al., 1994; Qin et al., 1994; Lassus et al., 1996; Preston et al., 1996; Bossy-Wetzel et al., 1997; Dijkers et al., 2000; Kumar et al., 2003) . Our study shows that this is also the case for Sp1. We also show that Sp1-induced apoptosis in contrast to other transcription factors such as c-Myc occurs even in the presence of growth factors such as IL-3 or serum. As a matter of fact, although deregulated expression of c-Myc induces apoptosis, it does so in low serum and c-Myc-induced apoptosis is inhibited by survival factor such as IGF-I (Harrington et al., 1994) . Therefore, Sp1 regulation of apoptosis seems to differ from c-Myc regulation of apoptosis. Some transcription factors such as p53 and human papillomavirus HPV E2 have been shown to exert their proapoptotic activity independently of transcription. (Demeret et al., 2003; Chipuk et al., 2004) . In the case of p53, cytosolic localization of endogenous wild-type protein is sufficient for apoptosis induction. Our results show that this is not the case for Sp1 as a truncated Sp1, deleted from its Apoptosis induction by Sp1 E Deniaud et al DNA-binding domain that is mainly localized in the cytoplasm, does not induce Baf-3 cells apoptosis. Therefore, Sp1 proapoptotic activity is either linked to its nuclear localization and/or to its DNA-binding activity. The latter hypothesis would indicate that Sp1 induces Baf-3 cells apoptosis through a transcriptiondependent mechanism. However, further investigations using forms of Sp1 unable to activate transcription but still localized in the nucleus will be required to determine whether this is the case. Sp1-binding sites are present in the promoters of many proapoptotic genes such as bax, fas, fas-ligand, trail, caspase-8 and caspase-3 (Black et al., 2001 ). Sp1-dependent expression of Fas-Ligand and TRAIL has been shown to be involved in the induction of apoptosis in different cell types (Kavurma et al., 2001; Nebbioso et al., 2005) . In hamster CCL39 fibroblasts, Sp1-induced apoptosis might involve a death receptor-activated pathway as it is inhibited by caspase-8 inhibitor. However, the expression of Fas or TRAIL could not be monitored as hamster-specific tools are currently not available. In contrast, in Baf-3 cells, Fas-Ligand and TRAIL are not detected at the mRNA level and their expression is not induced before the onset of Sp1-triggered apoptosis (Figure 6c) . Accordingly, although Fas-induced apoptosis in Baf-3 is inhibited by caspase-8 inhibitor, Sp1-induced apoptosis is not. In acute myeloid leukaemia cells Sp1-induced TRAIL upregulation is dependent on increased levels of histone acetylation leading to a greater accessibility of the trail promoter. Hence, as in Baf-3 cells TRAIL and FasLigand are not expressed, it is likely that their promoters are in an inactive conformation. Under these conditions, Sp1 overexpression on its own is not sufficient to induce their expression. Altogether, our result indicate that the mechanism by which Sp1 induces apoptosis in Baf-3 cells appears to be distinct from the ones previously described in other cell types.
Among the transcripts analysed by RNase protection assay (RPA), Bcl-X show the highest change in its levels of expression. bcl-x gene has Sp1-binding sites in its promoter (Grillot et al., 1997) and has been shown to be tightly regulated in Baf-3 cells (Leverrier et al., 1999; Rosa Santos et al., 2000) . Although the decrease of Bcl-X might sensitize the cells to apoptosis, this decrease is unlikely to be the cause of Baf-3 cell death as it has been previously shown that they can remain viable with minimal Bcl-X expression levels (Low et al., 2001) . Therefore, if Sp1-induced apoptosis proceeds through a transcriptional mechanism, the molecular targets involved remain to be identified in Baf-3 cells.
It has become increasingly evident that Sp1 plays a role in cancer. Firstly, Sp1 activity is increased following phosphorylation by oncogenic signalling pathways such as the RAS/RAF/MAPK and the PI3K/Akt pathways (Kivinen et al., 1999; Milanini-Mongiat et al., 2002; Pore et al., 2004) . Secondly, Sp1 is overexpressed and/or hyperactivated in a number of human tumours (Lietard et al., 1997; Zannetti et al., 2000; Shi et al., 2001; Chiefari et al., 2002; Wang et al., 2003) . Thirdly, Sp1 overexpression is required for the maintenance of the transformed phenotype as its downregulation in human fibrosarcoma cell lines inhibits their tumorigenicity (Lou et al., 2005) . This indicates that Sp1 overexpression or overactivation contributes to transformation. This effect could be achieved via the Sp1-dependent regulation of growth-promoting oncogenes such as IEX-1 and TCL1 (Im et al., 2002; French et al., 2003) . Involvement of Sp1 in cancer cell growth regulation is also strongly suggested by the growth inhibitory effect of dominantnegative Sp1 or Sp1-decoy oligodeoxynucleotides (Chen et al., 2000; Ishibashi et al., 2000; Chae et al., 2004) . Sp1 also favours cell transformation via the regulation of VEGF expression, a gene overexpressed in many tumours and that contributes to their neovascularization. Indeed, Sp1 overexpression consistently correlates with angiogenic potential in pancreatic adenocarcinoma (Shi et al., 2001) . Although Sp1 overexpression might be beneficial for tumour cells, our results highlight that high levels of Sp1 are detrimental in various untransformed cell lines. Therefore, it is tempting to speculate that tumour cells can only survive elevated Sp1 levels after they have acquired mechanisms that counteract Sp1 induction of apoptosis. This is supported by our data showing that Bcl-2 family members inhibit the apoptotic program activated by Sp1. This is also in agreement with experimental data showing that levels of Sp1 slowly increase during the process of transformation in a fibrosarcoma transformation model (Lou et al., 2005) .
Materials and methods
Materials
Caspase-8 inhibitor Z-Ile-Glu(Ome)-Thr-DL-Asp(Ome)-fluoromethylketone (Z-IETD-FMK, Bachem distribution, Weil am Rhein, Germany) and pan-caspase inhibitor Z-Val-Ala-DLAsp-fluoromethylketone (Z-VAD-FMK, Bachem) were resuspended in dimethyl sulphoxide (DMSO, Sigma-Aldrich, L'isle d'Abeau, France). Polyclonal rabbit antiserum was raised against recombinant full-length human Sp1 that has been histidine-tagged. Briefly, Sp1 cDNA was cloned in-frame into pQE32 plasmid (Qiagen SA, Courtaboeuf, France) and the histidine-Sp1 fusion protein was expressed and purified from Escherichia coli according to the manufacturer's protocol (Qiagen). Polyclonal rabbit serum was generated by Covalab (Lyon, France).
Cell culture
The murine bone marrow-derived IL-3-dependent Baf-3 cell line (Rodriguez-Tarduchy et al., 1990) was maintained in DMEM (Invitrogen SARL, Cergy Pontoise, France) containing 6% foetal bovine serum (FBS, Pan Biotech GmbH, Aidenbach, Germany), 2 mM L-glutamine (Gibco) and 5% WEHI 3B cell-conditioned medium as a source of IL-3. Baf-3 cells overexpressing the antiapoptotic genes bcl-x (Baf-Bcl-X) and nr-13 (Baf-Nr-13) have been characterized previously (Mangeney et al., 1996; Thomas et al., 1998) . 3T3 fibroblasts and the retrovirus packaging Phoenix cell line (GC Promochem Sarl, Molsheim, France) were maintained in DMEM containing 10% FCS and 2 mM L-glutamine. Hamster CCL39 fibroblast subclone (CCL39 WT2) expressing a tetracycline-inducible human full-length Sp1 has been described in details in (Milanini-Mongiat et al., 2002) . CCL39 WT2 cells were cultured in DMEM without phenol red containing 7.5% FBS and maintained under antibiotics selection. Twenty-four hours before tetracycline (Invitrogen SARL, Cergy Pontoise, France) stimulation, CCL39 WT2 cells were seeded in six-or 24-multiwell cell culture plate (BD Biosciences, Le Pont de Claix, France) at a density of 10 4 cells/cm 2 . To induce Fas-triggered apoptosis, Baf-3 cells were cultured for 18 h onto plastic wells coated with 2 mg/cm 2 of biotinylated Fas antibody (JO2, BD Biosciences) in the presence of cycloheximide 1 mg/ml (Sigma).
Retroviral constructions, transfections and transductions
The human Sp1 cDNA was excised as a 2.4 kb. XbaI/XmaI fragment from the plasmid pBS-Sp1-fl (a kind gift from Brian B Rudkin, Ecole Normale Supe´rieure de Lyon, France) and was inserted into pBluescript II SK( þ ). This form of Sp1 codes for Sp1 778 a form lacking the first seven amino acids in the N-terminal region. The entire human Sp1 protein consists of 785 amino acids (Bouwman and Philipsen, 2002) . Therefore, we have generated a construct coding for a full-length human Sp1 protein identical to the one described in the databases (accession no. P08047). To do so, the N-terminal sequence of Sp1 from pBSK-Sp1 was replaced using polymerase chain reaction (PCR) by the following sequence 5 0 -TGA GCT GCC ACC ATG TCC GAC CAA GAT CAC TCC ATG GAC GAA ATG ACA GCT GTG GTG-3 0 to give pBSK-Sp1 AN. The sequence was chosen so as to replace the potential out of frame 'start codon' (position 26) and to optimize the kozak sequence without affecting the protein sequence. A FLAGencoding sequence was inserted at the C-terminus of Sp1 into the pBSK-Sp1 AN plasmid by PCR at the BamHI/SalI site. A truncated form of Sp1 (Sp1DZn) lacking its DNAbinding domain that consists in three zinc-fingers (amino acids 621-708) was obtained by PCR-mediated deletion. The various constructs were sequenced before cloning into the bicistronic retroviral expression vector pMX-IRES-CD2 (a kind gift from Xuedong Liu, Boulder, CO, USA) (Liu et al., 2000) . The resulting constructs code for Sp1 followed by an internal ribosomal entry site and a truncated cell surface marker (CD2) to identify transduced cells. Tet-responsive enhanced green fluorescent protein (EGFP) expression construct was made by cloning EcoRI restriction fragments of fulllength cDNA of EGFP into pBABE SIN CMV 15-1 vector (a kind gift of Dr Turham, Paris, France) (Hofmann et al., 1996) . Full-length flagged human Sp1 AN cDNA was cloned into EcoRI sites of pRTP vector. pRTP (a kind gift of Dr Heinrich, Zurich, Switzerland) is a derivative of pBABE SIN CMV 15-1 vector carrying puromycin resistance gene (Heinrich et al., 2000) .
Ecotropic retroviral vectors were made by transfecting 10 mg of DNA into 2 Â 10 6 Phoenix packaging cells plated in a 60-mm tissue culture dish using a standard calcium phosphate transfection method. Twenty-four hours post-transfection the culture medium was replaced and supernatants containing the retroviruses were collected 48 h later and filtered through 0.45 mm filter.
Baf-3 or 3T3 cells were transduced by centrifugating (1100 g) 1.5 Â 10 5 cells for 90 min at room temperature in 0.5 ml of viral supernatants supplemented with 8 mg/ml polybrene (Sigma) and 25 ml WEHI 3B cell-conditioned medium in the case of Baf-3 cells. After completion of the spin, 1 ml of culture medium with polybrene was added. Twenty-four hours postinfection, cells were washed and cultured for the indicated times.
Inducible Baf-3-Sp1 cell line Baf-3 cells were first transduced with self-inactivating EGFP-IRES-tTA retroviruses. Cells that had low background EGFP in the presence of doxycyline (30 ng/ml, Sigma) and homogeneous high EGFP induction in the absence of doxycyline were selected by cell sorting (fluorescence-activated cell sorting (FACS)-Vantage, Becton-Dickinson, Immunocytometry Systems, San Jose, CA, USA) and then cloned by limiting dilution. One clone was transduced by pRTP Sp1-IRES-tTA retrovirus and selected with 5 mg/ml of puromycin. Single clones were obtained by limiting dilution and screened by PCR for pRTP Sp1-IRES-tTA retroviral integration into the genome and inducible Sp1 expression upon doxycyline removal.
FACS analysis
To detect cell surface expression of CD2, cells were incubated for 30 min with 4 mg/ml PE-coupled monoclonal antibody against murine CD2 (Pharmingen) in phosphate-buffered saline (PBS) containing 1% FBS. After one wash, 10 000 cells were counted on a FACScalibur (Becton-Dickinson) and analysed using the CellQuest software. Annexin V staining was performed as recommended by the manufacturers. Baf-3 cells were stained with annexin V-fluorescein isothiocyanate (FITC) (Pharmingen). Floating and adherent CCL39 cells were collected, pooled and stained with annexin V -Alexa568 (Roche). Caspase-3 activation was measured by FACS analysis as described previously (Gonin-Giraud et al., 2002) using a polyclonal rabbit antiactive caspase-3 antiserum (Pharmingen) and donkey anti-rabbit antiserum coupled to FITC (Jackson ImmunoResearch Laboratories Inc., West Grove, PA, USA). When required, cells were first stained with anti-CD2-PE as indicated above followed by staining with annexin V-FITC or antiactive caspase-3 antibody.
Immunofluorescence microscopy Thirty hours after transduction, Baf-3 cells were seeded on polylysine-coated 12-mm glass coverslips, fixed with 4% paraformaldehyde (BDH) in PBS then permeabilized with 0.25% Triton X-100 (BDH) in PBS. Specimens were then incubated for 120 min with 1:50 anti-Sp1 polyclonal rabbit followed by 30 min with biotin-conjugated goat anti-rabbit antibody (5 mg/ml, Jackson ImmunoResearch). Specimens were then incubated 30 min with FITC-conjugated streptavidin (1 mg/ml, Becton-Dickinson) and rhodamine-conjugated phalloidin (0.2 mg/ml, Sigma). Slides were mounted with ProLong antifade (Invitrogen SARL). Images of cells (single sections) were obtained using a Zeiss LSM 510 confocal laser-scanning microscope.
Magnetic selection and reverse transcription-polymerase chain reaction (RT-PCR) Thirty hours after transduction, cells were incubated with 5 mg biotinylated-anti-CD2 antibody (Pharmingen) per 10 7 cells and CD2-expressing cells were purified by magnetic selection using streptavidin microbeads according to the manufacturer's recommendations (Miltenyi Biotec, Paris, France).
Total cellular RNA was extracted using the RNA Now method (Ozyme, Saint Quentin en Yvelines, France) according to the manufacturer's instructions. RNA (1 mg) was incubated with 7 U of DNAse I (Amersham). After addition of ethylenediamine-N, N, N 0 , N 0 -tetraacetic acid (EDTA) 2.5 mM, samples were incubated at 651C for 15 min, then cooled at 41C for 5 min. Reverse transcription was performed with 200 U of Superscript II reverse transcriptase according to the manufacturer's recommendations (Invitrogen). LDH A and ubiquitin were amplified by incubating 2 ml of a 1:10 dilution of the reverse transcribed cDNA with 0.6 U Taq polymerase (Roche Diagnostics, France), 200 mM dNTP (MBI Fermentas Gmbh, St Leon-Rot, Germany), 100 nM of forward and reverse primers with a Perkin-Elmer, Courtaboeuf, France, 2400 Thermal Cycler. The PCR reaction was loaded onto 1.7% agarose gel containing ethidium bromide and observed under ultraviolet illumination. The sequences of the primers used are: LDH A forward primer: 5 0 -TCTGGGTGATGGGAGAAGAG-3 0 ; LDH A reverse primer 5 0 -AGGTGTGGGTGTACGTGTAG-3 0 ; ubiquitin forward primer 5 0 -AAGAATTCAGATCGGATGACACACT-3 0 ; ubiquitin reverse primer 5 0 -GCCACTTGGAGGTTGACACT TT-3 0 .
Western blot analysis Cells were washed in cold PBS and lysed as described (Mathieu et al., 2001) . Proteins, 50 mg, were separated on 10% Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to PVDF membranes (Millipore SAS, Molshein, France). The membranes were incubated with 1/1000 rabbit anti-Sp1 serum or 1/2000 mouse antiactin antibody (Sigma) for 16 h at 41C. Blots were then incubated with anti-rabbit-Cy5 or anti-mouse-Cy3 (Amersham) and the fluorescence was measured using a Typhoon 8600 (Amersham Biosciences, Orsay, France).
Multiprobe RPA Total cellular RNA was isolated by the RNA Now method (Ozyme) according to the manufacturer's instructions. mRNA levels were measured by RPA using the Riboquant kit (Pharmingen) following the supplier's instructions. The quantity of protected RNA was determined using the PhosphorImager Typhoon 8600 and the ImageQuant software (both from Molecular Dynamics, Sunnyvale, CA, USA).
Relative mRNA level was normalized using the internal control L32 mRNA.
Quantification by real-time PCR Real-time PCR analysis was carried out using Platinum SYBR Green qPCR SuperMix UDG kit (Invitrogen) on an ABI Prism 7700 (Perkin-Elmer). Mix were as follow: 10 ml platinum mix, 0.8 ml primer (10 mM), 0.6 ml Rox reference dye, 3.6 ml H 2 O and template in 5 ml. The following program was used, samples were incubated at 501C for 2 min, followed by 10 min at 951C, followed by 40 cycles (951C 10 s, 601C 1 min). The dissociation curve was measured for each sample. Relative level of the Sp1 sequence against the reference sequences (HPRT and ubiquitin) was calculated using the DDC t method with calculated real efficiencies. The sequences of primers used are: Sp1 forward primer: GCCTCCAGACCATTAACCTCAGT, Sp1 reverse primer: GCTCCATGATCACCTGGGGCA; HPRT forward primer TCATTA TGCCGAGGAT TTGGA; HPRT reverse primer: CAGAGGGCCA CAATGTGATG; ubiquitin foward primer: AAG AAT TCA GAT CGG ATG ACA CAC T, ubiquitin reverse primer: GCC ACT TGG AGG TTG ACA CTT T.
